Market Overview

Benzinga's Top Analyst Calls From April 6, 2018


These headlines first appeared on Benzinga Pro.

  • Cantor out defending NewLink Genetics Corp (NASDAQ: NLNK), says indoximod is differentiated vs epacadostat in response rates in more heavily pretreated patient population; thinks assuming failure of indoximod may be premature, but understands shares are likely pressured.
  • Buckingham Research maintains Buy rating and $15 target price on Gol Transportes Aéreos (NYSE: GOL), implying 20 percent upside. Says Gol's underlying fundamental outlook is “aided by a continued demand recovery in the context of a heavily restructured supply backdrop and commercial initiatives.”
  • KeyBanc upgrades Halyard Health, Inc. (NYSE: HYH) to Overweight, says upcoming events could raise growth expectations and restructuring and M&A efforts could drive accelerated EPS growth.
  • Mizuho out positive on Nektar Therapeutics (NASDAQ: NKTR), says Incyte’s (NASDAQ: INCY) epacadostat Phase 3 failure is a positive for the company, believes this news raises the possibility of a takeout by BMS in coming months.
  • Imperial Capital maintains Outperform rating on Halcón Resources Corp. (NYSE: HK), says co. is “ready to get active on its West Quito Draw position” following acquisition.

See Also:

Benzinga's Top Upgrades, Downgrades For April 6, 2018

5 Biggest Price Target Changes For Friday

Posted-In: Analyst Color Price Target Intraday Update Analyst Ratings


Related Articles (GOL + HK)

View Comments and Join the Discussion!

Latest Ratings

CNPRBC CapitalUpgrades34.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

HC Wainwright: Why The Upside Potential For Palatin Technologies Is Nearly Fivefold

Mid-Afternoon Market Update: Crude Oil Down 2%; PriceSmart Shares Spike Higher